SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-11-000044
Filing Date
2011-05-05
Accepted
2011-05-05 16:18:40
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q final1q10q2011_55.htm 10-Q 996199
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER exhibit31ceocert.htm EX-31.1 7348
3 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER exhibit31cfocert.htm EX-31.2 7534
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER exhibit32ceo.htm EX-32.1 3095
5 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER exhibit32cfo.htm EX-32.2 3369
  Complete submission text file 0000878088-11-000044.txt   1018643
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 11814909
SIC: 2834 Pharmaceutical Preparations